[go: up one dir, main page]

GR3032113T3 - Solid and liquid solutions of drugs which are not readily soluble in water. - Google Patents

Solid and liquid solutions of drugs which are not readily soluble in water.

Info

Publication number
GR3032113T3
GR3032113T3 GR990403157T GR990403157T GR3032113T3 GR 3032113 T3 GR3032113 T3 GR 3032113T3 GR 990403157 T GR990403157 T GR 990403157T GR 990403157 T GR990403157 T GR 990403157T GR 3032113 T3 GR3032113 T3 GR 3032113T3
Authority
GR
Greece
Prior art keywords
pct
water
drugs
solid
liquid solutions
Prior art date
Application number
GR990403157T
Other languages
English (en)
Inventor
Jens-Christian Wunderlich
Ursula Schick
Juergen Werry
Juergen Freidenreich
Original Assignee
Alfatec Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6462411&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3032113(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alfatec Pharma Gmbh filed Critical Alfatec Pharma Gmbh
Publication of GR3032113T3 publication Critical patent/GR3032113T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Colloid Chemistry (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR990403157T 1992-07-03 1999-12-16 Solid and liquid solutions of drugs which are not readily soluble in water. GR3032113T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4221880A DE4221880A1 (de) 1992-07-03 1992-07-03 Feste und flüssige Lösungen von schwer wasserlöslichen Arzneistoffen
PCT/DE1993/000592 WO1994001090A1 (de) 1992-07-03 1993-07-05 Feste und flüssige lösungen von schwer wasserlöslichen arzneistoffen

Publications (1)

Publication Number Publication Date
GR3032113T3 true GR3032113T3 (en) 2000-03-31

Family

ID=6462411

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990403157T GR3032113T3 (en) 1992-07-03 1999-12-16 Solid and liquid solutions of drugs which are not readily soluble in water.

Country Status (12)

Country Link
US (1) US5902606A (el)
EP (1) EP0650354B1 (el)
JP (1) JP2975112B2 (el)
AT (1) ATE187639T1 (el)
AU (1) AU688263B2 (el)
CA (1) CA2139133C (el)
DE (2) DE4221880A1 (el)
DK (1) DK0650354T3 (el)
ES (1) ES2139662T3 (el)
GR (1) GR3032113T3 (el)
PT (1) PT650354E (el)
WO (1) WO1994001090A1 (el)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0701815B1 (de) * 1992-01-17 1999-06-30 ALFATEC-PHARMA GmbH Verfahren zur Herstellung von Wirkstoff enthaltenden Pulvern, Granulaten oder Pellets mit einem Gerüst aus hydrophilen Makromolekülen und ihre Verwendung
US5449519C1 (en) * 1994-08-09 2001-05-01 Revlon Consumer Prod Corp Cosmetic compositions having keratolytic and anti-acne activity
US6118080A (en) * 1998-01-13 2000-09-12 Micron Technology, Inc. Z-axis electrical contact for microelectronic devices
US6555139B2 (en) * 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
ES2252048T3 (es) 1999-09-16 2006-05-16 Novo Nordisk A/S Composicion para fiv.
US20030149288A1 (en) * 2000-04-18 2003-08-07 Natural Asa Conjugated linoleic acid powder
AU2002214583A1 (en) * 2000-10-11 2002-04-22 Purdue Research Foundation Pharmaceutical applications of hydrotropic agents, polymers thereof, and hydrogels thereof
US20050158271A1 (en) * 2000-10-11 2005-07-21 Lee Sang C. Pharmaceutical applications of hydrotropic polymer micelles
DE10058771A1 (de) * 2000-11-27 2002-06-06 Falk Pharma Gmbh Coazervierungsverfahren zur Herstellung von verzögert feisetzenden Arzneimitteln
DE10058772A1 (de) * 2000-11-27 2002-06-06 Falk Pharma Gmbh Verfahren zur Herstellung leicht löslicher Arzneimittelformulierungen und entsprechende Formulierungen
US7119062B1 (en) 2001-02-23 2006-10-10 Neucoll, Inc. Methods and compositions for improved articular surgery using collagen
US20040013732A1 (en) * 2001-09-25 2004-01-22 Michael Farber Starch-based delivery system for creatine
JP2003221335A (ja) 2001-10-26 2003-08-05 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
US20030203930A1 (en) * 2001-10-26 2003-10-30 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US6702997B2 (en) 2001-10-26 2004-03-09 Dey, L.P. Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
US20030140920A1 (en) * 2001-10-26 2003-07-31 Dey L.P. Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma
US20030191151A1 (en) * 2001-10-26 2003-10-09 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
DE10205362A1 (de) * 2002-02-08 2003-08-21 Abbott Gmbh & Co Kg Verfahren zur Herstellung wasserdispergierbarer Trockenpulver von in Wasser schwer löslichen Verbindungen
US7067150B2 (en) 2002-04-16 2006-06-27 Scepter Holdings, Inc. Delivery systems for functional ingredients
JPWO2005018607A1 (ja) * 2003-08-20 2007-11-01 味の素株式会社 溶解性を改善した医薬品製剤
US7282217B1 (en) 2003-08-29 2007-10-16 Kv Pharmaceutical Company Rapidly disintegrable tablets
US20080160086A1 (en) * 2004-02-19 2008-07-03 Scepter Holdings, Inc. Delivery Systems For Calcium
EP4176906A1 (en) 2005-02-14 2023-05-10 Johnson & Johnson Vision Care, Inc. A comfortable ophthalmic device and methods of its production
US9052529B2 (en) 2006-02-10 2015-06-09 Johnson & Johnson Vision Care, Inc. Comfortable ophthalmic device and methods of its production
US9347947B2 (en) 2009-03-12 2016-05-24 Siemens Healthcare Diagnostics Inc. Immunoassays employing non-particulate chemiluminescent reagent
PT2879666T (pt) * 2012-08-01 2020-05-07 Tavakoli Zahra Composições congeladas, de fluxo livre contendo um agente terapêutico
DE102013207083A1 (de) 2013-04-19 2014-10-23 Leibniz-Institut Für Polymerforschung Dresden E.V. Verwendung von Chitosan und/oder dessen Derivaten in Baumaterialien
ES2731367T3 (es) 2016-02-11 2019-11-15 Gelpell Ag Formulaciones de cannabinoides sólidas orales, métodos para producir y utilizar las mismas
US20190083629A1 (en) 2016-04-29 2019-03-21 Rousselot B.V. Protein based excipient for active pharmaceutical ingredients
CN119913005B (zh) * 2025-01-22 2025-09-12 广州安来之健康管理有限责任公司 一种红花的油溶性提取物制备方法及应用的舒缓霜

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB887901A (el) * 1960-04-13 1900-01-01
US3435110A (en) * 1966-03-21 1969-03-25 Ethicon Inc Collagen fibril matrix pharmaceuticals
US3959472A (en) * 1972-04-10 1976-05-25 Hoffmann-La Roche Inc. Free-flowing, high density, agglomerated riboflavin powders
IE45770B1 (en) * 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
US4670247A (en) * 1983-07-05 1987-06-02 Hoffman-Laroche Inc. Process for preparing fat-soluble vitamin active beadlets
EP0285682B2 (en) * 1987-04-06 1997-08-06 F. Hoffmann-La Roche Ag Process for the manufacture of vitamin preparations
EP0140255B1 (en) * 1983-10-14 1991-05-15 Sumitomo Pharmaceuticals Company, Limited Sustained-release injections
JPS6144825A (ja) * 1984-08-09 1986-03-04 Unitika Ltd 止血剤
CA1324083C (en) * 1987-03-09 1993-11-09 Tetsu Miyoshi Pharmaceutical preparations containing non-steroidal anti-inflammatory agents
MC2034A1 (fr) * 1988-06-23 1990-05-30 Hoffmann La Roche Preparations
CH677141A5 (el) * 1988-09-16 1991-04-15 Rosenmund Ag
US4948580A (en) * 1988-12-08 1990-08-14 E. R. Squibb & Sons, Inc. Muco-bioadhesive composition
FR2650502B1 (fr) * 1989-08-07 1994-05-27 Delagrange Laboratoires Nouvelle forme galenique orale ameliorant la biodisponibilite
CA2071840C (en) * 1989-11-06 1997-02-04 Edith Mathiowitz Method for producing protein microspheres

Also Published As

Publication number Publication date
WO1994001090A1 (de) 1994-01-20
DK0650354T3 (da) 2000-05-29
AU4415293A (en) 1994-01-31
CA2139133C (en) 2001-09-18
DE59309907D1 (de) 2000-01-20
US5902606A (en) 1999-05-11
JP2975112B2 (ja) 1999-11-10
JPH07508525A (ja) 1995-09-21
AU688263B2 (en) 1998-03-12
PT650354E (pt) 2000-05-31
EP0650354A1 (de) 1995-05-03
DE4221880A1 (de) 1994-01-05
EP0650354B1 (de) 1999-12-15
ATE187639T1 (de) 2000-01-15
CA2139133A1 (en) 1994-01-20
ES2139662T3 (es) 2000-02-16

Similar Documents

Publication Publication Date Title
GR3032113T3 (en) Solid and liquid solutions of drugs which are not readily soluble in water.
ES2569949T3 (es) Formulaciones farmacéuticas que comprenden un péptido complejado con una dicetopiperazina
PL325825A1 (en) Microemulsion for use as a carrier for administering active compounds
EP0643963A3 (en) Biologically erodible device for the administration of active substances.
GB9126209D0 (en) Drug formulations for parenteral use
JP2001525363A5 (el)
ATE119771T1 (de) Behandlung von beschädigtem knochenmark und dosierungseinheiten dafür.
ATE386506T1 (de) Verabreichung unlöslicher arzneistoffe
DE69326350D1 (de) Pharmazeutische formulierung
ZA912793B (en) Pharmaceutical formulations
ATE192921T1 (de) Therapeutischer wirkstoff zur behandlung von melanomen
IL111131A (en) Emulsion formulation
KR910000703A (ko) 테트라졸 자극성 아미노산 수용체의 길항물질
EP0483370A4 (en) Percutaneous preparation containing estradiol
GR3025362T3 (en) Sol-controlled gelatine-based thermocolloidal matrix for peroral prolonged action administration forms.
GR3023962T3 (en) Drugs containing diphosphonic acids and salts thereof.
GB2328872B (en) Method for preparing pharmaceutical formulations
Roosen et al. A comparison of aspiration, antazoline sclerotherapy and surgery in the treatment of hydrocele
KR920703003A (ko) 혈관활성 바소토신 유도체
KR900000081A (ko) 트리암테렌의 약학적 액제
RU92016480A (ru) Аэрозольные композиции, содержащие лекарственный препарат
TH18176A (th) อิมัลชันชนิดน้ำมัน-ใน-น้ำ
KR910011249A (ko) 종합감기약 및 그 제조방법